Submit Deal

TAHOE THERAPEUTICS (FORMERLY VEVO THERAPEUTICS)

HQ - San Francisco, CA

Summary

Tahoe Therapeutics (formerly Vevo Therapeutics) is a biotechnology company using its in vivo drug discovery platform and next generation AI models to uncover better drugs for more patients.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 22 M

Avg. Deal Size£ 22 M

Market Context

Senior Management

Nima Alidoust
Co-Founder and CEO
Johnny Yu
Co-Founder and CSO
Hani Goodarzi
Co-Founder

Sort

11 Aug 2025|United States|Biotechnology

Target: TAHOE THERAPEUTICS (FORMERLY VEVO THERAPEUTICS)

Bidder: GENERAL CATALYST PARTNERS

2 Service Providers

1 Target | 1 Bidder

5 Dealmakers

4 Target | 1 Bidder

£ 22 M

Value